🇺🇸 FDA
Pipeline program

ASTX727, ASTX727, Decitabine, ASTX727

ASTX727-03

Phase 1 small_molecule active

Quick answer

ASTX727, ASTX727, Decitabine, ASTX727 for Myelodysplastic Syndromes (MDS) is a Phase 1 program (small_molecule) at Taiho Pharma Netherlands B.V. with 1 ClinicalTrials.gov record(s).

Program details

Company
Taiho Pharma Netherlands B.V.
Indication
Myelodysplastic Syndromes (MDS)
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials